TY - JOUR T1 - Response to Omalizumab in Solar Urticaria: Report of 3 Cases JO - Actas Dermo-Sifiliográficas T2 - AU - Rodríguez-Jiménez,P. AU - Chicharro,P. AU - Pérez-Plaza,A. AU - de Argila,D. SN - 15782190 M3 - 10.1016/j.adengl.2016.08.019 DO - 10.1016/j.adengl.2016.08.019 UR - https://actasdermo.org/en-response-omalizumab-in-solar-urticaria-articulo-S1578219017302408 AB - We report 3 cases of solar urticaria in which there was no response or limited response to first-line treatments with high-dose H1 antihistamines or phototherapy. The patients were then treated with omalizumab. Symptoms improved in 2 patients, whose tolerance to sunlight increased considerably; quality of life clearly improved for 1 of these patients. The third experienced no improvement and developed a mild local reaction to the injected medication. We conclude that omalizumab may offer a potentially safe, useful alternative for patients with solar urticaria who do not respond to conventional therapy. ER -